Congratulations to our Co-Founder Farren Isaacs, Scientific Advisor Jesse Rinehart, and their groups on their publication in @Nature!
The "Ochre" next-generation GRO is a key aspect of our platform to develop multi-functional, smart biologics. @Yale
https://t.co/Jb6yhyZ6OT
Amazing news for @NUSynBio startup @PearlBio cofounded by @MichaelCJewett. The company which counts famed entrepreneur @geochurch as one of its scientific advisers, uses ”genomically recoded organisms” to add synthetic chemistry to biologics.
@PearlBio, a #syntheticbiology company, unveiled a collaboration with @Merck (known as #MSD outside of the U.S. and Canada) on March 12. The $1 billion partnership aims at discovering novel biologic therapies incorporating non-standard amino acids.
https://t.co/hirQw3GDDJ
Synthetic biology company @PearlBio announced Tuesday it has entered into a license and collaboration agreement with @Merck to discover biologic therapies comprising non-standard amino acids.
#pharma#biospace
https://t.co/5W9ENl22Wx
We're excited to announce a partnership with @Merck to develop multi-functionalized "smart" biologics with tunable properties.
@khoslaventures@FierceBiotech
https://t.co/iD5LiAtie0
@PearlBio (https://t.co/WHn17zpfhl), a company co-founded with Farren Isaacs @Yale and Amy Schwartz with seed funding from @khoslaventures, has struck it's first pharma deal based on our genomically recoded organism technologies for biotherapeutics
https://t.co/VaqTE6dUwg
Absolutely thrilled to join forces with the amazing team at @PearlBio! 🎉 Huge congratulations on this incredible collaboration! 🚀 Can't wait to achieve many more goals together!
We're excited to announce a partnership with @Merck to develop multi-functionalized "smart" biologics with tunable properties.
@khoslaventures@FierceBiotech
https://t.co/iD5LiAtie0
We are #hiring a Senior/Principal Scientist at Pearl! Join our team in using cutting edge #synbio to create transformative therapeutics.
https://t.co/rlpD2NBqbA